Update on systemic therapy for clear cell renal cell carcinoma

被引：1
|
作者：
Muehlmann, Josef [1 ]
机构：
[1] Hosp Barmherzige Bruder Bros Mercy, Dept Internal Med, Kajetanerpl 1, A-5020 Salzburg, Austria
来源：
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY | 2023年 / 16卷 / 01期
关键词：
Adjuvant therapy; Belzutifan; First-line therapy; Second-line therapy; Pembrolizumab; PHASE-III; COMBINATION; RISK;
D O I：
10.1007/s12254-022-00867-w
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The treatment landscape of advanced and metastatic renal cell carcinoma (RCC) has changed fundamentally over the last two decades with the introduction of tyrosine kinase inhibitors (TKIs) in 2005 and immune checkpoint inhibitors (ICIs) about 10 years later, both demonstrating significantly improved overall survival (OS) rates across all RCC risk categories. Currently, combination therapies represent the standard-of-care in the first-line setting of clear cell RCC in almost all cases. In this short review article, the most recent therapeutic advances in early and advanced stage of clear cell RCC are summarized.
引用
收藏
页码：38 / 41
页数：4
相关论文
共 50 条
  • [21] Update on systemic therapies of metastatic renal cell carcinoma
    E. Herrmann
    S. Bierer
    C. Wülfing
    [J]. World Journal of Urology, 2010, 28 : 303 - 309
  • [22] Update on systemic therapies of metastatic renal cell carcinoma
    Herrmann, E.
    Bierer, S.
    Wuelfing, C.
    [J]. WORLD JOURNAL OF UROLOGY, 2010, 28 (03) : 303 - 309
  • [23] Non clear cell renal cell carcinoma. 2008 update in renal tumor pathology
    Sibony, Mathilde
    Vieillefond, Annick
    [J]. ANNALES DE PATHOLOGIE, 2008, 28 (05) : 381 - 401
  • [24] Clear cell renal cell carcinoma
    Grignon, DJ
    Che, MX
    [J]. CLINICS IN LABORATORY MEDICINE, 2005, 25 (02) : 305 - +
  • [25] Clear Cell Renal Cell Carcinoma
    Erickson, Lori A.
    [J]. MAYO CLINIC PROCEEDINGS, 2018, 93 (06) : 813 - 814
  • [26] Advanced systemic mastocytosis as a mimicker of metastatic clear cell renal cell carcinoma
    Walz, Christoph
    Subklewe, Marion
    Horny, Hans-Peter
    Flaig, Michael
    Reiter, Andreas
    Kirchner, Thomas
    Sotlar, Karl
    [J]. LEUKEMIA RESEARCH, 2012, 36 (06) : 799 - 801
  • [27] Systemic sarcoidosis during pazopanib treatment for clear cell renal cell carcinoma
    Vaccaro, Mario
    Borgia, Francesco
    Lentini, Maria
    Gaeta, Michele
    Marafioti, Ilenia
    [J]. INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2023, 89 (03): : 444 - 446
  • [28] Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma
    Ingels, Alexandre
    Campi, Riccardo
    Capitanio, Umberto
    Amparore, Daniele
    Bertolo, Riccardo
    Carbonara, Umberto
    Erdem, Selcuk
    Kara, Onder
    Klatte, Tobias
    Kriegmair, Maximilian C.
    Marchioni, Michele
    Mir, Maria C.
    Ouzaid, Idir
    Pavan, Nicola
    Pecoraro, Angela
    Roussel, Eduard
    de la Taille, Alexandre
    [J]. NATURE REVIEWS UROLOGY, 2022, 19 (07) : 391 - 418
  • [29] Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma
    Alexandre Ingels
    Riccardo Campi
    Umberto Capitanio
    Daniele Amparore
    Riccardo Bertolo
    Umberto Carbonara
    Selcuk Erdem
    Önder Kara
    Tobias Klatte
    Maximilian C. Kriegmair
    Michele Marchioni
    Maria C. Mir
    Idir Ouzaïd
    Nicola Pavan
    Angela Pecoraro
    Eduard Roussel
    Alexandre de la Taille
    [J]. Nature Reviews Urology, 2022, 19 : 391 - 418
  • [30] Renal Toxicity of Systemic Therapy for Renal Cell Carcinoma
    Jaimes, Edgar A.
    [J]. SEMINARS IN NEPHROLOGY, 2020, 40 (01) : 49 - 58
12345